94 related articles for article (PubMed ID: 10697399)
21. [Detection and localization of multiple metastases from differentiated thyroid carcinoma with 99mTc-MIBI whole body scintigraphy: a case report].
Kosuda S; Arai S; Soya T; Toshima H; Kusano S
Kaku Igaku; 1994 Oct; 31(10):1243-8. PubMed ID: 7807728
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
Kosuda S; Yokoyama H; Katayama M; Yokokawa T; Kusano S; Yamamoto O
Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
[TBL] [Abstract][Full Text] [Related]
23. Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans.
Küçük ON; Aras G; Kulak HA; Ibiş E
Nucl Med Commun; 2006 Nov; 27(11):873-6. PubMed ID: 17021427
[TBL] [Abstract][Full Text] [Related]
24. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
Nagamachi S; Jinnouchi S; Nishii R; Flores LG; Nakahara H; Futami S; Tamura S; Toshimori H; Kawai K
Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
[TBL] [Abstract][Full Text] [Related]
26. [Usefulness of 99mTc-MIBI SPECT in the metastatic lesions of thyroid cancer].
Kobayashi M; Mogami T; Uchiyama M; Moriya E; Mori Y; Ohtani Y; Kawakami K; Asahara R
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Feb; 57(3):127-32. PubMed ID: 9077095
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
28. The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences.
Spanu A; Farris A; Schillaci O; Chessa F; Solinas ME; Falchi A; Madeddu G; Nuvoli S; Madeddu G
Nucl Med Commun; 2003 Feb; 24(2):145-54. PubMed ID: 12548039
[TBL] [Abstract][Full Text] [Related]
29. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
[No Abstract] [Full Text] [Related]
30. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.
Nakahara H; Noguchi S; Murakami N; Hoshi H; Jinnouchi S; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
J Nucl Med; 1996 Jun; 37(6):901-4. PubMed ID: 8683308
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
Learoyd DL; Roach PJ; Briggs GM; Delbridge LW; Wilmshurst EG; Robinson BG
J Nucl Med; 1997 Feb; 38(2):227-30. PubMed ID: 9025742
[TBL] [Abstract][Full Text] [Related]
33. [99m-Tc-MIBI for recurrent and metastatic differentiated thyroid carcinoma].
Elser H; Henze M; Hermann C; Eckert W; Mende U
Nuklearmedizin; 1997 Jan; 36(1):7-12. PubMed ID: 9082340
[TBL] [Abstract][Full Text] [Related]
34. [Clinical value of 99mTc-MIBI imaging, 131I whole body scan and HTG determination for the follow-up of patients with differentiated thyroid carcinoma after 131I therapy].
Yu N; Guan C; Liu Y; Yang X
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):437-9. PubMed ID: 11387963
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of 131I-whole body scintigraphy in the after care of differentiated thyroid cancer].
Hüfner M; Stumpf HP; Hermann HJ; Kimmig B
Dtsch Med Wochenschr; 1983 Aug; 108(33):1234-8. PubMed ID: 6307629
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of [99mTC]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome.
Roelants V; Michel L; Lonneux M; Lacrosse M; Delgrange E; Donckier JE
Acta Clin Belg; 2001; 56(6):373-7. PubMed ID: 11881324
[TBL] [Abstract][Full Text] [Related]
37. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
[TBL] [Abstract][Full Text] [Related]
40. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan.
Kaya M; Cermik TF
Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]